Evidence for a pathogenetic role of interleukin‐18 in cutaneous lupus erythematosus
Authors:
Open Access
- 29 September 2008
- journal article
- systemic lupus-erythematosus
- Published by Wiley in Arthritis & Rheumatism
- Vol. 58 (10) , 3205-3215
Abstract
Objective: Cutaneous manifestations are the most common clinical features of lupus erythematosus (LE). The aim of this study was to analyze differences in the inflammatory response of keratinocytes from patients with cutaneous LE (CLE) compared with healthy controls.Methods: Keratinocytes from LE patients and controls were cultured from epidermal stem cells of the hair follicle of anagen head hairs. Functional responses of keratinocytes to cytokine stimulation were determined by flow cytometry and enzyme‐linked immunosorbent assay. Biopsy samples of lesional skin were analyzed by immunohistochemistry.Results: Keratinocytes from CLE patients expressed higher levels of IL‐18 receptor on their cell surface in response to tumor necrosis factor α (TNFα) or interferon‐γ stimulation. In response to IL‐18 stimulation, these cells produced large amounts of TNFα. Of note, in the presence of IL‐18, CLE keratinocytes failed to express IL‐12. IL‐12 has previously been shown to protect keratinocytes from ultraviolet irradiation–induced apoptosis. Keratinocytes from LE patients were more prone to die upon exposure to IL‐18, and this increased apoptosis was abrogated by blockade of endogenously produced TNFα as well as by the addition of exogenous IL‐12. IL‐18 was highly expressed in biopsy samples of lesional skin from CLE patients.Conclusion: Our results demonstrate an intrinsic difference in the inflammatory response of keratinocytes and indicate an autocrine feedback loop involving TNFα, IL‐18, and IL‐12 family members. Our results suggest that IL‐18 may occupy an important position in the cytokine hierarchy in CLE, indicating the potential benefit of a local agent that blocks IL‐18 activity in the treatment of the manifestations of CLE.Keywords
This publication has 49 references indexed in Scilit:
- Why Does Rheumatoid Arthritis Involve the Joints?New England Journal of Medicine, 2007
- The TNFα locus is altered in monocytes from patients with systemic lupus erythematosusClinical Immunology, 2007
- Clearance deficiency and systemic lupus erythematosus (SLE)Journal of Autoimmunity, 2007
- Interaction of keratinocytes with infiltrating lymphocytes in allergic eczematous skin diseasesCurrent Opinion in Allergy and Clinical Immunology, 2006
- Expression of Interleukin-18 and Caspase-1 in Cutaneous T-Cell LymphomaClinical Cancer Research, 2006
- Elevated interleukin-18 levels correlated with disease activity in systemic lupus erythematosusClinical Rheumatology, 2004
- IL-12 Completely Blocks Ultraviolet-Induced Secretion of Tumor Necrosis Factor α from Cultured Skin Fibroblasts and KeratinocytesJournal of Investigative Dermatology, 2003
- Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repairNature Cell Biology, 2001
- Association of a Promoter Polymorphism of Tumor Necrosis Factor-α with Subacute Cutaneous Lupus Erythematosus and Distinct Photoregulation of Transcription1,21Werth VP, Sullivan K: Strong association of a promoter polymorphism of tumor necrosis factors α with a photosensitive form of cutaneous lupus erythematosus. Arthr Rheum 42:S105 1999 (abstr.)2Werth VP, Zhang W, Sullivan K: Role of a promoter polymorphism of tumor necrosis factor-α (TNF-α) in a photosensitive form of lupus erythematosus (LE): clinical association and distinct photoregulation of transcription. J Invest Dermatol 114:770 2000 (abstr.)Journal of Investigative Dermatology, 2000
- Reversal of ultraviolet radiation‐induced immune suppression by recombinant interleukin‐12: suppression of cytokine productionImmunology, 2000